
The Centers for Disease Control and Prevention said that younger males should consider waiting longer between doses of Pfizer Inc's (NYSE:PFE) / BioNTech SE (NASDAQ:BNTX) and Moderna Inc's (NASDAQ:MRNA) COVID-19 vaccines to reduce a rare risk of heart inflammation.
The CDC said males ages 12- to 39-years-old should consider waiting eight weeks between the first and second doses of their primary COVID-19 vaccination series, writes CNBC.